Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 322
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07865260 PhiCube-Adults — PhiCube for Bilateral Upper Limb Neuromotor and Cognit… |
PhiCube | Sclérose latérale amyotrophique | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Istituto di Sistemi e Tecnologie … | Italy · Istituti Clinici Scientifici Maugeri IRCCS, B… | 2026-09 → 2027-09 | Ouvrir |
| NCT07863180 BUTTER2 — Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual … |
Tributyrin | Parkinson | Phase 1/2 | RECRUITING | En attente / non publié | Prabesh Kanel | United States · Domino's Farms, Ann Arbor, United Sta… | 2026-09 → 2027-05 | Ouvrir |
| NCT06439355 PI-PEG — Single-center Study of Gustation in Idiopathic Parkinson's Dis… |
Fasting blood test | Parkinson | Non applicable | RECRUITING | En attente / non publié | Centre Hospitalier Universitaire … | France · CHU Dijon Bourgogne, Dijon, France | 2024-05-27 → 2027-05 | Ouvrir |
| NCT05824728 AGB101 PDP — Clinical Trial Evaluating the Efficacy and Safety of AGB10… |
AGB101 | Parkinson | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Johns Hopkins University | United States · Johns Hopkins, Baltimore, United Stat… | 2023-09-28 → 2026-12 | Ouvrir |
| NCT03924856 Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Ver… |
Pembrolizumab | Parkinson | Phase 3 | COMPLETED | En attente / non publié | Merck Sharp & Dohme LLC | United States, Australia, Belgium, Canada, Denmark, F… | 2019-06-13 → 2026-05-18 | Ouvrir |
| NCT07673146 Probing Gut-Brain Communication in Parkinson's Disease |
taVNS | Parkinson | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Spaulding Rehabilitation Hospital | Non communiqué | 2027-01-01 → 2031-07-01 | Ouvrir |
| NCT06647277 Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease |
Fecal Microbiota Transplant | Parkinson | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | ProgenaBiome | United States · Sabine Hazan, Ventura, United States | 2027-07 → 2027-12 | Ouvrir |
| NCT07868614 Intraoperative Microelectrode Recordings Using MAVEN Compared to Standa… |
Multifunctional Apparatus for Vol… | Parkinson | À vérifier | RECRUITING | En attente / non publié | Mayo Clinic | United States · Mayo Clinic, Rochester, United States | 2025-07-29 → 2028-12-01 | Ouvrir |
| NCT07464028 TAME-PD: — Terazosin And Metabolic Energetics in Parkinson's Disease |
Terazosin 5 MG | Parkinson | Phase 2 | SUSPENDED | En attente / non publié | Ergun Y. Uc | United States · University of Iowa, Iowa City, United… | 2028-07-01 → 2031-07-01 | Ouvrir |
| NCT00024622 PET Scanning in Parkinson s Disease |
O-15 Water | Parkinson | À vérifier | COMPLETED | En attente / non publié | National Institute of Mental Heal… | United States · National Institutes of Health Clinica… | 2002-03-15 | Ouvrir |
| NCT07787299 PD-WATCH — Wearable for Assessing Tremor and Continuous Health in Parki… |
Device exposure: Wearable inertia… | Parkinson | À vérifier | RECRUITING | En attente / non publié | Heriot-Watt University | United Kingdom · Clinical Research Facility, Western … | 2026-11-01 → 2027-12-31 | Ouvrir |
| NCT03648905 Clinical Laboratory Evaluation of Chronic Autonomic Failure |
13N-Ammonia | Parkinson | À vérifier | COMPLETED | En attente / non publié | National Institute of Neurologica… | United States · National Institutes of Health Clinica… | 2018-09-06 → 2026-07-15 | Ouvrir |
| NCT02119611 Deep Brain Stimulation Therapy in Movement Disorders |
Deep Brain Stimulation management | Parkinson | Non applicable | RECRUITING | En attente / non publié | National Institute of Neurologica… | United States · National Institutes of Health Clinica… | 2014-04-02 → 2030-12-01 | Ouvrir |
| NCT04261569 Clinical Trial for Near Infrared Endoventricular Illumination for Neuro… |
Ev-NIRT | Parkinson | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | University Hospital, Grenoble | France · CLINATEC, Grenoble, France | 2020-12-14 → 2032-04 | Ouvrir |
| NCT01010802 Safety Study of Erythropoietin (EPO) in Parkinson's Disease |
Erythropoietin human recombinant … | Parkinson | Phase 1 | COMPLETED | En attente / non publié | International Center for Neurolog… | Cuba · Clinic of Movement Disorders, International Ce… | 2008-08 → 2009-05 | Ouvrir |
| NCT07080775 The Safety,Tolerability, Efficacy of XS411 Cell Injection for the Treat… |
human allogeneic induced pluripot… | Parkinson | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | XellSmart Therapeutics (Shanghai)… | China · Beijing Tiantan Hospital, Beijing, China | 2025-08-05 → 2028-07 | Ouvrir |
| NCT06285643 A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGEN… |
AAV2-GDNF gene therapy | Parkinson | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | AskBio Inc | United States, Germany, Poland, United Kingdom · CenE… | 2024-06-11 → 2028-08-31 | Ouvrir |
| NCT06565195 PROSPECT-PD — A Clinical Trial of LY3962681 in Healthy Volunteers and i… |
LY3962681 | Parkinson | Phase 1 | RECRUITING | En attente / non publié | Prevail Therapeutics | United States, Germany, Japan, Netherlands, United Ki… | 2024-08-27 → 2030-07-23 | Ouvrir |
| NCT04957095 Motor Network Physiology |
Apomorphine Injectable Solution | Parkinson | Non applicable | RECRUITING | En attente / non publié | University of Texas Southwestern … | United States · UT Southwestern Medical Center, Dalla… | 2022-02-18 → 2028-12-01 | Ouvrir |
| NCT06015841 VacSYn — A Study to Evaluate the Effects of ACI-7104.056 in Patients Wi… |
ACI-7104.056 at Dose A | Parkinson | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | AC Immune SA | Germany, Spain, United Kingdom · Hospital de la Santa… | 2023-07-24 → 2028-06 | Ouvrir |
| NCT06582212 Lady-PD — Enabling Women With Parkinson's Disease to Identify and Bette… |
Mymovesmatter mobile application | Parkinson | Non applicable | RECRUITING | En attente / non publié | University Hospital, Grenoble | France · CHU Grenoble Alpes, Grenoble, France | CHU N… | 2025-03-12 → 2027-09-12 | Ouvrir |
| NCT07706829 Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-P… |
Smartwatch and phone app | Parkinson | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Queen Mary University of London | France, Spain, United Kingdom · Centre Hospitalier Un… | 2026-10-01 → 2027-09-30 | Ouvrir |
| NCT04736706 A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6… |
Pembrolizumab | Parkinson | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Australia, Brazil, Canada, Chile, Chin… | 2021-04-14 → 2027-04-22 | Ouvrir |
| NCT07709741 Sustained Release Oral Formulation For Treatment Of Parkinsons Disease |
Formulation A | Parkinson | Phase 1/2 | NOT_YET_RECRUITING | En attente / non publié | University of Minnesota | United States · University of Minnesota, Minneapolis,… | 2027-04-01 → 2027-06-30 | Ouvrir |
| NCT07797790 INHALE-PD — Real-world Patient Experiences With Inbrija® |
Levodopa inhalation powder | Parkinson | À vérifier | RECRUITING | En attente / non publié | Merz Therapeutics GmbH | Austria · Medizinischen Universität Graz, Graz, Austr… | 2026-09 → 2027-09 | Ouvrir |